Benjamin T. Kile
Chief Tech/Sci/R&D Officer at MuriGen Pty Ltd.
Profile
Benjamin T.
Kile is currently the Chief Scientific Officer at MuriGen Pty Ltd.
He previously worked at Baylor College of Medicine as a Principal.
Benjamin T. Kile active positions
| Companies | Position | Start |
|---|---|---|
MuriGen Pty Ltd.
 MuriGen Pty Ltd. Pharmaceuticals: MajorHealth Technology MuriGen Pty Ltd. discovers, develops and commercializes drugs. It develops drugs for cancer, arthritis, thrombocytopenia, inflammatory diseases, epilepsy and thalassemia. The company was founded by Douglas James Hilton on September 28, 1999 and is headquartered in Melbourne, Australia. | Chief Tech/Sci/R&D Officer | 2010-04-22 |
Former positions of Benjamin T. Kile
| Companies | Position | End |
|---|---|---|
| Baylor College of Medicine | Corporate Officer/Principal | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
MuriGen Pty Ltd.
MuriGen Pty Ltd. Pharmaceuticals: MajorHealth Technology MuriGen Pty Ltd. discovers, develops and commercializes drugs. It develops drugs for cancer, arthritis, thrombocytopenia, inflammatory diseases, epilepsy and thalassemia. The company was founded by Douglas James Hilton on September 28, 1999 and is headquartered in Melbourne, Australia. | Health Technology |
- Stock Market
- Insiders
- Benjamin T. Kile
